Stock Analysis tagged as


  1. Celgene Set to Squeeze Short Sellers (CELG, IBB)

  2. Show Time at Aralez Pharmaceuticals Inc. (ARLZ)

  3. Political Headwinds Dampen Gilead Sciences Outlook

  4. Top 3 Biotech Companies Awaiting FDA Approval

  5. DURECT Corporation: Near-Term Approval Likely for REMOXY

  6. Biotech Bottom Calls After Big Bounce (IBB, XBI)

  7. Big Biotech Set to Bounce Off Deep Lows (GILD, CELG)

  8. Biotech Funds Selling Off at Resistance (IBB, XBI)

  9. 3 Biotech Stocks Headed for New Highs (SCLN, SUPN)

  10. Finding Perfect Pullback Prices (SCLN, BRKR)

  11. 3 Hot Momentum Plays in a Cold Market (NVDA, AG)

  12. Take Advantage of Biotech's Bear Market Bounce (IBB, CELG)

  13. 3 Round Number Setups at 100

  14. Curb Your Enthusiasm With the Biotech Bounce

  15. 3 Low-priced Stocks Set to Head Higher

  16. 3 Plays for the Biotech Bear Market (GILD, UTHR)

  17. Zika Plays Ready to Break Out (XON, INO)

  18. Why Biotech Affimed N.V. Should Be On Your Radar (JUNO, AFMD)

  19. Roth Capital Reiterates Buy on Three Pharma Stocks

  20. Two Biotechs Worth A Look Ahead Of FDA Approvals (BDSI, SPPI)

  21. Analysts Bullish on BioDelivery Ahead of FDA Event (BDSI, ENDP)

  22. Analyst Bullish on Peregrine Following Q2 Update

  23. Analysts Bullish on OHR Pharma Amid Positive Study

  24. Celgene To Buy Receptos For $7.2B; Analysts Mixed

  25. Celgene's $1 Billion Deal to Fight Cancer

  26. Sarepta Therapeutics One Step Closer to Drug Approval

  27. OvaScience Releases Positive Data for Flagship Therapy

  28. The Future of 3D Printing in Biopharmaceuticals (ONVO, SSYS)

  29. The Best- and Worst-Performing Healthcare Stocks

  30. Investing In Biotech: Is It Worth The Risk?

  31. Biotechnology Stocks To Keep on the Radar

  32. Overlooked Israel Is A Portfolio Growth Engine

  33. Little Known Stocks And ETFs To Buy As Interest Rates Rise

  34. How To Hedge Your Grocery Bill- Higher Prices Are Coming

Trading Center